NewzPT Bio Farma (Persero) and the Murdoch Children’s Research Institute (MCRI) have achieved a significant milestone after receiving marketing authorization from Indonesia's Food and Drug Authority (BPOM RI) for their neonatal rotavirus vaccine, Bio-RV.
The newly approved vaccine is the result of a collaborative development effort between the Indonesian state-owned pharmaceutical enterprise and the Australian research institute. It is specifically designed as a neonatal rotavirus vaccine to address health challenges related to the virus.
In-depth summary · AI, neutral